NESS ZIONA, Israel, Nov. 02, 2022 (GLOBE NEWSWIRE) — BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that the Company will host a conference call and a live audio webcast on Wednesday, November 9, 2022, at 8:00 a.m. ET, to report third quarter 2022 financial results and provide business updates.
To participate in the conference call, please dial 1-877-407-0724 (U.S.) or 1-201-389-0898 (International). The live and archived webcast will be available in the Investors section of the Company’s website at www.biomx.com.
About BiomX
BiomX is a clinical-stage microbiome company developing both natural and engineered phage cocktails designed to target and destroy bacteria in the treatment of chronic diseases. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets.
Additional information is available at www.biomx.com, the content of which does not form a part of this press release.
BiomX, Inc.
Anat Primovich
Corporate Project Manager
+97250-6977228
anatp@biomx.com
Investor Relations:
LifeSci Advisors, LLC
John Mullaly
jmullaly@lifesciadvisors.com
Source: BiomX Inc
OVERLAND PARK, Kan., April 15, 2025 /PRNewswire/ -- Dendi, a leading cloud-native laboratory information system (LIS)…
HARTFORD, Conn., April 15, 2025 /PRNewswire/ -- Hartford HealthCare (HHC) is honored to announce that…
Rice Business presents world's largest and richest student startup competition HOUSTON, April 15, 2025 /PRNewswire/…
High-quality care seamlessly integrates with healthcare benefits navigation app to improve member experience and ensure…
TORRANCE, Calif., April 15, 2025 /PRNewswire/ -- Compex Legal Services, a leading national provider of medical…
Sponsorship will enhance, strengthen resources for the Northern Kentucky-based life sciences and entrepreneurship lab incubator…